[Clinical tolerance of rifampycin administered alone or in combination with other antitubercular drugs].
D000293:Adolescent; D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D001798:Blood Proteins; D004357:Drug Synergism; D004977:Ethambutol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D000637:Transaminases / Q000097:blood; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D001798:Blood Proteins; D004977:Ethambutol; D000637:Transaminases; D012293:Rifampin
La tollerabilità in campo clinico della rifampicina impiegata da sola ed in assoicazione ad altri farmaci antitubercolari.